- Home
- SYBX vs APCX Comparison
SYBX vs APCX Comparison
Compare SYBX & APCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- APCX
- Stock Information
- Founded
- SYBX N/A
- APCX 2006
- Country
- SYBX United States
- APCX United States
- Employees
- SYBX N/A
- APCX N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- APCX Finance: Consumer Services
- Sector
- SYBX Health Care
- APCX Finance
- Exchange
- SYBX Nasdaq
- APCX Nasdaq
- Market Cap
- SYBX 16.5M
- APCX 12.6M
- IPO Year
- SYBX N/A
- APCX N/A
- Fundamental
- Price
- SYBX $1.20
- APCX $0.38
- Analyst Decision
- SYBX Hold
- APCX
- Analyst Count
- SYBX 1
- APCX 0
- Target Price
- SYBX N/A
- APCX N/A
- AVG Volume (30 Days)
- SYBX 10.2K
- APCX 224.9K
- Earning Date
- SYBX 03-06-2025
- APCX 03-31-2025
- Dividend Yield
- SYBX N/A
- APCX N/A
- EPS Growth
- SYBX N/A
- APCX N/A
- EPS
- SYBX N/A
- APCX N/A
- Revenue
- SYBX $8,000.00
- APCX $365,000.00
- Revenue This Year
- SYBX N/A
- APCX $1,315.48
- Revenue Next Year
- SYBX N/A
- APCX N/A
- P/E Ratio
- SYBX N/A
- APCX N/A
- Revenue Growth
- SYBX N/A
- APCX N/A
- 52 Week Low
- SYBX $1.15
- APCX $0.31
- 52 Week High
- SYBX $2.04
- APCX $1.70
- Technical
- Relative Strength Index (RSI)
- SYBX 30.51
- APCX 41.85
- Support Level
- SYBX $1.15
- APCX $0.38
- Resistance Level
- SYBX $1.33
- APCX $0.43
- Average True Range (ATR)
- SYBX 0.07
- APCX 0.04
- MACD
- SYBX -0.01
- APCX -0.00
- Stochastic Oscillator
- SYBX 19.23
- APCX 6.25
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About APCX AppTech Payments Corp.
AppTech Payments Corp is a FinTech company utilizing various payment processing and digital banking technologies to complement core merchant services capabilities. The company's patented and proprietary software will provide progressive and adaptable products that are available through a suite of synergistic offerings directly to merchants, banking institutions, and business enterprises. It is developing a secure digital payments and banking platform that powers commerce experiences for clients and customers. Based upon industry standards for payment and banking protocols, the company will offer standalone products and fully integrated solutions that deliver unparalleled payments, banking, and financial services experiences.